Associated Banc-Corp’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-943
Closed -$474K 311
2023
Q2
$474K Hold
943
0.02% 234
2023
Q1
$472K Hold
943
0.02% 233
2022
Q4
$385K Hold
943
0.02% 247
2022
Q3
$307K Sell
943
-86
-8% -$31.6K 0.01% 256
2022
Q2
$361K Sell
1,029
-129
-11% -$52.6K 0.02% 248
2022
Q1
$633K Hold
1,158
0.02% 217
2021
Q4
$762K Sell
1,158
-15
-1% -$9.42K 0.03% 207
2021
Q3
$729K Sell
1,173
-123
-9% -$82.6K 0.03% 209
2021
Q2
$818K Sell
1,296
-525
-29% -$290K 0.03% 204
2021
Q1
$441K Buy
1,821
+578
+47% +$290K 0.03% 211
2020
Q4
$621K Sell
1,243
-112
-8% -$50.1K 0.02% 255
2020
Q3
$533K Sell
1,355
-148
-10% -$54.7K 0.02% 251
2020
Q2
$496K Sell
1,503
-318
-17% -$92.1K 0.02% 256
2020
Q1
$441K Buy
+1,821
New +$475K 0.02% 260

Other funds holding IDXX

Associated Banc-Corp's IDXX Position: Q3 2023 in Review

Associated Banc-Corp sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 943 shares — an estimated $474K sold.

Associated Banc-Corp first reported a position in IDXX in Q1 2020 and held it in 14 quarters. The position peaked at $818K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Associated Banc-Corp reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Associated Banc-Corp sold 943 Idexx Laboratories shares in Q3 2023, an estimated $474K.
  • Associated Banc-Corp first reported a position in Idexx Laboratories in Q1 2020 and held it in 14 quarters.
  • Associated Banc-Corp's Idexx Laboratories position peaked at $818K in Q2 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Associated Banc-Corp's 13F filing for Q3 2023, filed 9 Nov 2023.